Lilly Goes Beyond Weight Loss: $2.88B Merida Deal Targets Autoimmune Growth Posted on August 31, 2026 by http://wealthcreation.club ‼️ Eli Lilly will acquire Merida Biosciences for up to $2.88 billion in cash to broaden its autoimmune and allergy portfolio beyond its weight-loss and diabetes franchises. Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Published by http://wealthcreation.club http://wealthcreation.club—We are educating regular people about how to be able to make more money in a disciplined way View all posts by http://wealthcreation.club